Ozempic and Zepbound are both prescription injections that are part of the GLP-1 drug class. They have different active ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...

Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to ...

Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

The healthcare worker warns that most people will put two thirds of the weight back on within a year of coming off the ...

As the popularity of the type-2 diabetes drugs have risen, researcher have been looking into different aspects of it to ensure safety. One such research has shown that it could help prevent cognitive ...

Demand for glucagon-like peptide-1 weight-loss drugs — such as Ozempic, Zepbound and Wegovy — coupled with limited insurance coverage has fueled a risky but growing “gray” market for purchasing active ...

Dozens of lawmakers are urging US health regulators to crack down on the booming market for knockoff weight-loss drugs amid ...